Latest On Raia Drogasil S.A (RADLY):
About Raia Drogasil S.A (RADLY):
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of September 30, 2020, the company operated a network of 2,223 drug stores in 23 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo and Tocantins. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
General
- Name Raia Drogasil S.A
- Symbol RADLY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryPharmaceutical Retailers
- Full Time Employees 44,631
- Last Split Factor5:1
- Last Split Date2020-10-01
- Fiscal Year EndDecember
- Web URLhttp://www.rd.com.br
Valuation
- Trailing PE 11.9
- Forward PE 47.17
- Price/Sales (Trailing 12 Mt.) 1.97
- Price/Book (Most Recent Quarter) 9.02
- Enterprise Value Revenue 0.42
- Enterprise Value EBITDA 3.99
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 2%
- Return on Assets 5%
- Return on Equity 12%
- Earnings Per Share $0.42
- Revenue Per Share $0
- Gross Profit 5.89 billion
- Quarterly Earnings Growth 16.1%
Highlights
- Market Capitalization 8.72 billion
- Book Value Per Share $2.69
Share Statistics
- Shares Outstanding 1.65 billion
- Shares Float 749.16 million
- % Held by Insiders <1%
- % Held by Institutions 0.06%
Technicals
- Beta 0.55
- 52 Week High $7.05
- 52 Week Low $2.09
- 50 Day Moving Average 4.52
- 200 Day Moving Average 4.65
Dividends
- Forward Annual Dividend Rate $0.02
- Forward Annual Dividend Yield 0.5%
- Payout Ratio 38%
- Dividend Date 2021-06-10
- ExDividend Date 2021-03-18
- Dividend Per Share $0.16
- Dividend Yield 0%
Raia Drogasil S.A (RADLY) Dividend Calendar:
RADLY's last dividend payment was made to shareholders on June 10, 2021.
Raia Drogasil S.A pays out 38% of its earnings out as a dividend.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Raia Drogasil S.A (RADLY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $5.55 billion | $0.02 | ||
2020-09-30 | 2020-09-30 | $5.09 billion | $0.02 | ||
2020-06-30 | 2020-09-30 | $N/A | $0.02 | ||
2020-03-31 | 2020-06-30 | $4.95 billion | $0.01 | ||
2019-12-31 | 2020-03-31 | $4.79 billion | $0.01 | ||
2019-09-30 | 2019-12-31 | $4.6 billion | $0.01 | ||
2019-06-30 | 2019-09-30 | $4.23 billion | $0.07 | ||
2019-03-31 | 2019-06-30 | $3.95 billion | $0.02 | ||
2018-12-31 | 2019-03-31 | $4 billion | $0.01 | ||
2018-09-30 | 2018-12-31 | $3.76 billion | $0.02 | ||
2018-06-30 | 2018-09-30 | $3.61 billion | $0.02 | ||
2018-03-31 | 2018-06-30 | $3.43 billion | $0.02 | ||
2017-12-31 | 2018-03-31 | $3.5 billion | $0.02 | ||
2017-09-30 | 2017-12-31 | $3.42 billion | $0.02 | ||
2017-06-30 | 2017-09-30 | $3.24 billion | $0.03 | ||
2017-03-31 | 2017-06-30 | $3.06 billion | $0.03 | ||
2016-12-31 | 2017-03-31 | $3.06 billion | $0.02 | ||
2016-09-30 | 2016-12-31 | $0.02 | |||
2016-06-30 | 2016-09-30 | $0.02 | $0.00 | ||
2016-03-31 | 2016-06-30 | $0.03 | $0.00 | ||
2015-12-31 | 2016-03-31 | $0.02 | $0.00 | ||
2015-09-30 | 2015-12-31 | $0.01 | $0.00 | ||
2015-06-30 | 2015-09-30 | $0.01 | $0.00 | ||
2015-03-31 | 2015-06-30 | $0.02 | $0.00 | ||
2014-12-31 | 2015-03-31 | $0.01 | $0.00 | ||
2014-09-30 | 2014-12-31 | $0.01 | $0.00 | ||
2014-06-30 | 2014-09-30 | $0.02 | $0.00 | ||
2014-03-31 | 2014-06-30 | $0.02 | $0.00 | ||
2013-12-31 | 2014-03-31 | $0.01 | $0.00 | ||
2013-09-30 | 2013-12-31 | $0.01 | $0.00 | ||
2013-06-30 | 2013-09-30 | $0.01 | $0.00 | ||
2013-03-31 | 2013-06-30 | $0.01 | $0.00 | ||
2012-12-31 | 2013-03-31 | $0.00 | $0.00 | ||
2012-09-30 | 2012-12-31 | $0.00 | $0.00 | ||
2012-06-30 | 2012-09-30 | $0.01 | $0.00 | ||
2012-03-31 | 2012-06-30 | $0.01 | $0.00 | ||
2011-12-31 | 2012-03-31 | $0.01 | $0.00 | ||
2011-09-30 | 2011-12-31 | $0.00 | $0.00 | ||
2011-06-30 | 2011-09-30 | $0.01 | $0.00 | ||
2011-03-31 | 2011-06-30 | $0.02 | $0.00 | ||
2010-12-31 | 2011-03-31 | $0.01 | $0.00 | ||
2010-09-30 | 2010-12-31 | $0.01 | $0.00 |
Raia Drogasil S.A (RADLY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | N/A | N/A |
Income Before Tax | 197.26 million | 202.27 million | N/A | 167.6 million | 82.98 million |
Selling General Administrative | 1.35 billion | 1.21 billion | N/A | 1.19 billion | 1.14 billion |
Gross Profit | 1.63 billion | 1.49 billion | N/A | 1.44 billion | 1.41 billion |
Ebit | 611.7 million | 561.37 million | N/A | 507.88 million | 271.94 million |
Operating Income | 272.18 million | 283.29 million | N/A | 253.37 million | 271.94 million |
Income Tax Expense | 27 million | N/A | 3.03 million | N/A | -11.95 million |
Total Revenue | 5.55 billion | 5.09 billion | N/A | 4.95 billion | 4.79 billion |
Cost of Revenue | 3.92 billion | 3.6 billion | N/A | 3.51 billion | 3.37 billion |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | -188.96 million |
Net Income From Continuing Operations | 170.27 million | 155.02 million | N/A | 124.04 million | 94.93 million |
Net Income Applicable to Common Shares | 161.72 million | N/A | 44.68 million | N/A | 85.96 million |
Cash Flow:
Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
---|---|---|---|---|---|
Investments | -184.45 million | N/A | -180.34 million | N/A | N/A |
Change to Liabilities | N/A | -553.02 million | N/A | 371.2 million | 272.87 million |
Total Cash Flow from Investing Activities | N/A | -110.4 million | N/A | 123.54 million | 210.19 million |
Net Borrowings | N/A | 234.52 million | N/A | -482.54 million | 95.1 million |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | -791.6 million | 95.05 million |
Change to Operating Activities | N/A | 111.55 million | N/A | -19.16 million | -152.47 million |
Change in Cash | 333.79 million | N/A | 234.48 million | -177.31 million | 331.15 million |
Total Cash from Operating Activities | 647.38 million | -284.39 million | 294.91 million | 490.74 million | 25.91 million |
Depreciation | 272.61 million | N/A | 285.24 million | 227.58 million | 247.54 million |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | 1000 | -1000 |
Change to Inventory | 185.23 million | N/A | -104.54 million | -380.89 million | -357.37 million |
Change to Account Receivables | N/A | N/A | N/A | 12.24 million | -72.57 million |
Other Cash Flow from Financing Activities | N/A | -107.02 million | N/A | -216.1 million | N/A |
Change to Net Income | N/A | -32.23 million | N/A | 218.61 million | -404.15 million |
Capital Expenditures | 187.23 million | N/A | 177.06 million | 193.62 million | 143.75 million |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Total Liabailities | 9.4 billion | 8.82 billion | N/A | 8.87 billion | 8.17 billion |
Total Stockholder Equity | 4.36 billion | 4.17 billion | N/A | 4.1 billion | 4.03 billion |
Other Current Liabilities | 218.89 million | N/A | N/A | N/A | 238.91 million |
Total Assets | 13.83 billion | 13.04 billion | N/A | 13.03 billion | 12.25 billion |
Common Stock | 2.5 billion | N/A | 2.5 billion | N/A | 2.5 billion |
Other Current Assets | N/A | N/A | N/A | N/A | N/A |
Retained Earnings | 1.73 billion | 177.14 million | 1.44 billion | 76.36 million | 1.41 billion |
Other Liabilities | 551.31 million | N/A | 564 million | N/A | 577.55 million |
Other Assets | 525.42 million | N/A | 462.18 million | N/A | 432.51 million |
Cash | 880.36 million | 600.21 million | N/A | 533.71 million | 299.23 million |
Total Current Liabilities | 4.8 billion | 4.19 billion | N/A | 4.49 billion | 4.08 billion |
Other Stockholder Equity | 129.48 million | N/A | 119.35 million | N/A | 13.79 million |
Property, Plant & Equipment | 5.02 billion | N/A | 4.9 billion | N/A | 4.81 billion |
Total Current Assets | 7.02 billion | 6.36 billion | N/A | 6.37 billion | 5.76 billion |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | 3.1 billion | N/A | 2.81 billion | N/A | 2.78 billion |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | 1.12 billion | 1.2 billion | N/A | 879.72 million | 897.82 million |
Inventory | 4.23 billion | 3.93 billion | N/A | 3.93 billion | 3.85 billion |
Accounts Payable | 3.11 billion | 2.34 billion | N/A | 2.78 billion | 2.65 billion |
Raia Drogasil S.A (RADLY) Chart:
Raia Drogasil S.A (RADLY) News:
Below you will find a list of latest news for Raia Drogasil S.A (RADLY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Raia Drogasil S.A (RADLY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Raia Drogasil S.A (RADLY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|